CD44 and breast carcinoma: In this model, the oligonucleotide-based therapeutic-treated cells were characterized by a decrease in CD44 and an increase in the amount of CD24 protein on the cell surface, which may be related to the differentiation of breast cancer cells related to losing stem-like phenotypes.